Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia
Condition(s):Prostatic HyperplasiaLast Updated:October 17, 2017Withdrawn
Hide Studies Not Open or Pending
Condition(s):Prostatic HyperplasiaLast Updated:October 17, 2017Withdrawn
Condition(s):Lymphoma; Hyperplasia Lymphoid ReactiveLast Updated:May 30, 2017Unknown status
Condition(s):Endometrial HyperplasiaLast Updated:November 12, 2012Unknown status
Condition(s):Benign Prostatic HyperplasiaLast Updated:January 24, 2024Not yet recruiting
Condition(s):Pain, Postoperative; Wound Heal; Gingival HyperplasiaLast Updated:April 13, 2022Completed
Condition(s):Benign Prostatic Hyperplasia (BPH)Last Updated:December 20, 2022Completed
Condition(s):Fibrous Hyperplasia on Oral MucosaLast Updated:November 27, 2017Completed
Condition(s):Congenital Adrenal HyperplasiaLast Updated:March 22, 2022Unknown status
Condition(s):Benign Prostatic HyperplasiaLast Updated:June 14, 2019Completed
Condition(s):Prostatic HyperplasiaLast Updated:November 6, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.